Marginal Zone Lymphoma — Trials

Marginal Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

407 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 111
Recruiting: 62
Ph III recruiting: 2
Growth YoY: —
Industry share: 22%
Top sponsor: City of Hope Medical Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (79)

clinicaltrialsPublishedShowing 1–18 of 18 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07759661	Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies(IMPACT)	not yet recruiting	—	64	IRCCS San RaffaeleOTHER	1	Aug 13, 2026	clinicaltrials
NCT07744750	Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma	not yet recruiting	Phase 2	40	Changzhou No.2 People's HospitalOTHER	1	Aug 6, 2026